...
首页> 外文期刊>The Science of the Total Environment >Bioremediation of bezafibrate and paroxetine by microorganisms from estuarine sediment and activated sludge of an associated wastewater treatment plant
【24h】

Bioremediation of bezafibrate and paroxetine by microorganisms from estuarine sediment and activated sludge of an associated wastewater treatment plant

机译:河口沉积物和相关废水处理厂的活性污泥中的微生物对苯扎贝特和帕罗西汀进行生物修复

获取原文
获取原文并翻译 | 示例

摘要

The present work aimed to explore the potential of autochthonous microorganisms from an urban estuary and from activated sludge of an associated wastewater treatment plant (WWTP), for biodegradation of an antidepressant drug, paroxetine, and on a cholesterol-lowering agent, bezafibrate. These compounds were chosen as representatives of extensively used pharmaceuticals. Autochthonous microorganisms from the indicated sources were exposed to the target pharmaceuticals (1 mg/L) in co-metabolism with sodium acetate (500 mg/L) along a two-weeks period, for a total of 7 two-weeks periods (here referred as cycles). Exposures were carried out in batch mode, under different incubation conditions (agitation vs. static). Removal of pharmaceuticals was monitored at the end of each cycle, by analysing the culture medium. For paroxetine, fluoride ion release was also followed as an indicator of defluorination of the molecule. The structure of the bacterial communities was analysed by ARISA (Automated rRNA Intergenic Spacer Analysis), at the beginning of the experiment and at the end of the first and the last cycles to identify substantial changes associated with the time of exposure, the incubation conditions and the presence and type of pharmaceuticals. Incubation conditions affected not only the bacterial community structure, but also the biodegradation efficiency. At the beginning of the experiment, removal of target pharmaceuticals was found to be lower under agitation than under static conditions, but at the end of the experiment, results showed high removal of the pharmaceuticals from the culture medium ( 97%) under both conditions, mainly by microbiological processes. For paroxetine, adsorption and abiotic processes also had an important influence on its removal, but defluorination only occurred in the presence of microorganisms. These results highlight that autochthonous microorganisms from estuarine sediments and WWTP sludge have high ability to remove the selected pharmaceuticals with relevant implications for the development of new bioremediation tools for environmental restoration. (C) 2018 Elsevier B.V. All rights reserved.
机译:本工作旨在探索城市河口和相关废水处理厂(WWTP)的活性污泥中的本地微生物对抗抑郁药帕罗西汀和降胆固醇剂苯扎贝特的生物降解潜力。选择这些化合物作为广泛使用的药物的代表。在两周的时间内,将来自指定来源的本地微生物与乙酸钠(500 mg / L)共同代谢与目标药物(1 mg / L)接触,共7个两周时间(此处指作为周期)。在不同的孵育条件下(搅拌与静态)以分批方式进行暴露。在每个循环结束时,通过分析培养基来监测药物的去除。对于帕罗西汀,还跟踪氟离子的释放,作为分子脱氟的指标。在实验开始时以及在第一个和最后一个循环结束时,通过ARISA(自动rRNA基因间隔分析)分析细菌群落的结构,以确定与暴露时间,孵育条件和药品的存在和类型。孵育条件不仅影响细菌群落结构,而且影响生物降解效率。在实验开始时,发现搅拌下目标药物的去除率比静态条件下要低,但是在实验结束时,结果表明在两种条件下从培养基中去除药物的率都很高(> 97%) ,主要是通过微生物过程。对于帕罗西汀而言,吸附和非生物过程也对其去除有重要影响,但是脱氟仅在微生物存在下发生。这些结果表明,河口沉积物和污水处理厂污泥中的本地微生物具有很高的去除所选药物的能力,这对开发用于环境修复的新型生物修复工具具有重要意义。 (C)2018 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号